Brazil is an official Federative Republic of Brazil. It is the fifth largest country by both area and population. Brazil is the largest country to have Portuguese as an official language, and the only one in the Americas. It is bounded by Atlantic ocean and has a coastline of 7,491 kilometers. It occupies 47.3% of south America continent. Its Amazon River basin includes a vast tropical forest, home to diverse wildlife, a variety of ecological systems, and extensive natural resources spanning numerous protected habitats. This unique environmental heritage makes Brazil one of 17 megadiverse countries. Brazil is a part of the UN along with other global alliances such as G8, and the G20.
Brazil prompted to seek further information on new ANVISA Clincial Research Regulations. ANVISA stands for the Agencia Nacional de Vigilancia Sanitaria, a governmental regulatory agency responsible for establishing regulations applicable to clinical trials and drug pricing. Clinical science research in Brazil covers the subjects of Asthma, AIDS, Chemotherapy, Diabetes Mellitus, Cancer and heart diseases, etc.
Brazil's most esteemed technological hubs are the Oswaldo Cruz Institute, the Butantan Institute, the Air Force's Aerospace Technical Center, the Brazilian Agricultural Research Corporation and the INPE. Brazil also has a large number of outstanding scientific personalities. Among the most renowned Brazilian inventors are priests Bartolomeu de Gusmão, Landell de Moura and Francisco João de Azevedo, besides Alberto Santos-Dumont, Evaristo Conrado Engelberg, Manuel Dias de Abreu, Andreas Pavel e Nélio José Nicolai. Current clinical science research in brazil is focused on Zika virus, genetics, and on cancer. Brazil invented Medical Marijuana, Inc.'s HempMeds Brasil(TM) Product RSHO(TM) as Fourth Indication as a Prescription for Import: Cancer, which is Approved by Brazilian Government. Brazil has many clinical science journals.